Literature DB >> 11291107

Effect of substrate size on immunoinhibition of amylase activity.

I Warshawsky1, G L Hortin.   

Abstract

Immunoinhibition assays are hypothesized to work by antibodies blocking substrate access to enzyme active sites. To test this hypothesis, the inhibition of amylase isoenzymes by monoclonal and polyclonal antisera was assessed using substrates of varying sizes: chromogenic sustrates 3, 5, or 7 glucose units in length, novel synthetic macromolecular substrates, and starch. The synthetic macromolecular substrates consisted of small oligosaccharide substrates linked to an inert polymer that conferred a large size to substrate molecules as determined by gel filtration chromatography. When substrate size increased, amylase activity could be inhibited equivalently by antibody concentrations that are 10-fold lower. Progressively less polyclonal serum was required to inhibit amylase activity as substrate length increased from 3 to 5 to 7 glucose units and as size was increased by linkage to a polymer. Different effects of substrate size were observed with two monoclonal antibodies. One monoclonal antibody blocked amylase activity independent of substrate size, while another monoclonal antibody had little inhibitory effect except using starch as substrate. We conclude that use of larger substrates can expand the repertoire of inhibitory epitopes on enzymes and convert a noninhibitory antibody into an inhibitory one.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291107      PMCID: PMC6807950          DOI: 10.1002/jcla.3

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  20 in total

1.  Mechanism by which antibodies inhibit hapten-malate dehydrogenase conjugates. An enzyme immunoassay for morphine.

Authors:  G L Rowley; K E Rubenstein; J Huisjen; E F Ullman
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

Review 2.  Amylase and lipase in the emergency department evaluation of acute pancreatitis.

Authors:  R J Vissers; R B Abu-Laban; D F McHugh
Journal:  J Emerg Med       Date:  1999 Nov-Dec       Impact factor: 1.484

3.  Creatine kinase-MB by immunoinhibition in the diagnosis of suspected acute myocardial infarction.

Authors:  D S Ooi; M J Maddock; J F Livesey; J G Donnelly
Journal:  Clin Biochem       Date:  1996-10       Impact factor: 3.281

4.  Specific immunoassay of alpha-amylase isoenzymes in human serum.

Authors:  M Gerber; K Naujoks; H Lenz; W Gerhardt; K Wulff
Journal:  Clin Chem       Date:  1985-08       Impact factor: 8.327

5.  Hydrodynamic characterization of random coil polymers by size exclusion chromatography.

Authors:  P G Squire
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

6.  Use of high-performance size-exclusion chromatography to measure protein molecular weight and hydrodynamic radius. An investigation of the properties of the TSK 3000 SW column.

Authors:  R C Tarvers; F C Church
Journal:  Int J Pept Protein Res       Date:  1985-11

7.  Subsite mapping of the human pancreatic alpha-amylase active site through structural, kinetic, and mutagenesis techniques.

Authors:  G D Brayer; G Sidhu; R Maurus; E H Rydberg; C Braun; Y Wang; N T Nguyen; C M Overall; S G Withers
Journal:  Biochemistry       Date:  2000-04-25       Impact factor: 3.162

Review 8.  Electrophoretic assays of amylase isoenzymes and isoforms.

Authors:  T E Mifflin; G Hortin; D E Bruns
Journal:  Clin Lab Med       Date:  1986-09       Impact factor: 1.935

9.  Corrected sequences of cDNAs for human salivary and pancreatic alpha-amylases [corrected].

Authors:  T Nishide; M Emi; Y Nakamura; K Matsubara
Journal:  Gene       Date:  1984-05       Impact factor: 3.688

10.  A monoclonal antibody that specifically inhibits human salivary alpha-amylase.

Authors:  M Gerber; K Naujoks; H Lenz; K Wulff
Journal:  Clin Chem       Date:  1987-07       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.